SPY299.08+3.64 1.23%
DIA250.25+5.37 2.19%
IXIC9,340.22+15.63 0.17%

SVB Leerink Reiterates Outperform on Gossamer Bio, Raises Price Target to $36

SVB Leerink reiterates Gossamer Bio (NASDAQ:GOSS) with a Outperform and raises the price target from $27 to $36.

Benzinga · 05/20/2020 09:40

SVB Leerink reiterates Gossamer Bio (NASDAQ:GOSS) with a Outperform and raises the price target from $27 to $36.